Concept information
Preferred term
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Type
-
mesh:Descriptor
Definition
- A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from human papillomaviruses of these subtypes.
Broader concept
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- antagonists & inhibitors (Qualifier)
- biosynthesis (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- genetics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
In other languages
-
French
-
Vaccin recombinant quadrivalent contre les papillomavirus humains (types 6, 11, 16, 18)
-
Vaccin recombinant quadrivalent contre les papillomavirus humains (types 6, 11, 16, et 18)
-
Vaccin recombinant quadrivalent contre les virus du papillome humain (types 6, 11, 16 et 18)
-
Vaccin recombinant quadrivalent contre les virus du papillome humain (types 6, 11, 16, 18)
-
Vaccin recombinant quadrivalent contre les virus du papillome humain de type 6, 11, 16 et 18
URI
http://data.loterre.fr/ark:/67375/JVR-R8N3LL7Q-S
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}